复合药房市场规模、份额和增长分析（按治疗领域、年龄组、类型、不孕性别和地区）- 行业预测 2025-2032

复合药局市场规模预计将到 2023 年达到 152 亿美元，并从 2024 年的 160.8 亿美元增长到 2032 年的 252.5 亿美元，预测期内（2025-2032 年）的复合年增长率为 5.8%。

复合药房市场预计将增长，原因有几个，包括专利到期的增加、预期寿命的增加以及老年人口的增加。配药药房专门製造个人化药物，满足患者的特定需求，通常是在非处方药不可用的情况下。这些药物可以配製成各种剂型，包括调味液体、乳霜、凝胶和栓剂，由执业医师开立处方。 2021 年，成年人占据了 47% 的市场占有率，配药药房也提供营养补充剂以支持日常健康。此外，与不良生活方式相关的慢性病发病率不断上升，可能会进一步刺激对复合解决方案的需求，从而加速未来几年的市场扩张。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 客户和购买标准分析

配药药房市场规模（按治疗领域和复合年增长率） (2025-2032)

• 市场概况
• 荷尔蒙补充疗法
• 疼痛管理
• 专科药物
• 皮肤科
• 营养补充品
• 其他的

配药药房市场规模（按年龄组别划分）及复合年增长率（2025-2032 年）

• 市场概况
• 孩子们
• 成人
• 老年人

配药药房市场规模（按类型和复合年增长率） (2025-2032)

• 市场概况
• 药物成分变更 (PIA)
• 目前无法使用的药品製造 (CUPM)
• 药物剂量调整 (PDA)
• 其他的

配药药房市场规模：无菌性和复合年增长率（2025-2032）

• 市场概况
• 已灭菌
• 非无菌

配药药房市场规模（按地区划分）及复合年增长率（2025-2032 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• B. Braun Melsungen AG（Germany）
• Fagron NV（Belgium）
• Fresenius Kabi AG（Germany）
• Becton, Dickinson and Company（United States）
• McGuff Compounding Pharmacy Services Inc.（United States）
• Village Compounding Pharmacy（United States）
• Dougherty's Pharmacy, Inc.（United States）
• Institutional Pharmacy Solutions（United States）
• Lorraine's Pharmacy（United States）
• Triangle Compounding Pharmacy（United States）
• Custom Med Apothecary（United States）
• Olympia Pharmacy（United States）
• Precision Compounding Pharmacy（United States）
• College Pharmacy（United States）

结论和建议

Compounding Pharmacy Market size was valued at USD 15.2 billion in 2023 and is poised to grow from USD 16.08 billion in 2024 to USD 25.25 billion by 2032, growing at a CAGR of 5.8% during the forecast period (2025-2032).

The Compounding Pharmacy Market is poised for growth driven by several key factors, including a rise in patent expirations, longer life expectancy, and a growing elderly demographic. Compounding pharmacies specialize in creating personalized medications that cater to the specific needs of patients, often when commercial options are unavailable. These medications can be formulated into diverse dosage forms such as flavored liquids, creams, gels, and suppositories, as prescribed by licensed physicians. In 2021, adults constituted 47% of the market share, with compounding pharmacies also offering nutritional supplements to support daily wellness. Furthermore, the increasing prevalence of chronic diseases linked to poor lifestyle choices will further fuel the demand for compounded solutions, accelerating market expansion in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Compounding Pharmacy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Compounding Pharmacy Market Segments Analysis

Global Compounding Pharmacy Market is segmented by Therapeutic Area, Age Cohort, Type, Sterility and region. Based on Therapeutic Area, the market is segmented into Hormone Replacement Therapy, Pain Management, Specialty Drugs, Dermatology, Nutritional Supplements and Others. Based on Age Cohort, the market is segmented into Pediatric, Adult and Geriatric. Based on Type, the market is segmented into Pharmaceutical Ingredient Alteration (PIA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Pharmaceutical Dosage Alteration (PDA) and Others. Based on Sterility, the market is segmented into Sterile and Non-sterile. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Compounding Pharmacy Market

The Compounding Pharmacy market is expected to experience a compound annual growth rate (CAGR) exceeding 6% until 2028, largely fueled by the growing preference for oral pharmaceuticals, such as tablets and capsules. This rise in demand is attributed to the fact that many medical conditions can be most effectively managed through oral administration of medications. As patients increasingly seek convenient and effective treatment options, the reliance on orally delivered pharmaceuticals is set to expand, further propelling growth in the Compounding Pharmacy sector. This trend signifies a notable shift towards customized solutions in the pharmaceutical industry.

Restraints in the Compounding Pharmacy Market

The Compounding Pharmacy market is facing challenges due to an increase in the number of drugs that are prohibited from being compounded in large quantities. For instance, the U.S. FDA announced in June 2015 that it would restrict certain medications, including acetaminophen, aprotinin (Trasylol), ondansetron hydrochloride (Zofran), and bromocriptine mesylate (Tylenol), from being compounded by external institutions. This regulation could lead to a significant decline in demand for commonly compounded pharmaceuticals such as Tylenol, thereby adversely impacting the sales potential of compounded products from complex drug pharmacies. This restraint poses a notable hurdle for market growth and sustainability.

Market Trends of the Compounding Pharmacy Market

The compounding pharmacy market is poised for significant growth, driven by heightened research and development in topical formulations such as gels, creams, and ointments. As pharmaceutical companies prioritize innovative solutions to meet specific patient needs and preferences, the demand for customized medications continues to rise. Factors such as an increasing prevalence of skin-related issues, the rising geriatric population, and a growing emphasis on personalized medicine are further propelling this trend. Consequently, the compounding pharmacy sector is becoming a vital component of the healthcare landscape, paving the way for advanced therapeutic options tailored to individual patient requirements.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Customer And Buying Criteria Analysis

Global Compounding Pharmacy Market Size by Therapeutic Area & CAGR (2025-2032)

• Market Overview
• Hormone Replacement Therapy
• Pain Management
• Specialty Drugs
• Dermatology
• Nutritional Supplements
• Others

Global Compounding Pharmacy Market Size by Age Cohort & CAGR (2025-2032)

• Market Overview
• Pediatric
• Adult
• Geriatric

Global Compounding Pharmacy Market Size by Type & CAGR (2025-2032)

• Market Overview
• Pharmaceutical Ingredient Alteration (PIA)
• Currently Unavailable Pharmaceutical Manufacturing (CUPM)
• Pharmaceutical Dosage Alteration (PDA)
• Others

Global Compounding Pharmacy Market Size by Sterility & CAGR (2025-2032)

• Market Overview
• Sterile
• Non-sterile

Global Compounding Pharmacy Market Size & CAGR (2025-2032)

• North America (Therapeutic Area, Age Cohort, Type, Sterility)
  • US
  • Canada
• Europe (Therapeutic Area, Age Cohort, Type, Sterility)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Therapeutic Area, Age Cohort, Type, Sterility)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Therapeutic Area, Age Cohort, Type, Sterility)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Therapeutic Area, Age Cohort, Type, Sterility)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fagron NV (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McGuff Compounding Pharmacy Services Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Village Compounding Pharmacy (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dougherty's Pharmacy, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Institutional Pharmacy Solutions (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lorraine's Pharmacy (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Triangle Compounding Pharmacy (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Custom Med Apothecary (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympia Pharmacy (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precision Compounding Pharmacy (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• College Pharmacy (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations